not losing weight on semaglutide should i switch to tirzepatide Switching Between and Tirzepatide: Efficacy, Dosing Protocols, and What Expect Switching From Tirzepatide to Semaglutide:

68 Similarly, the STEP 4 trial demonstrated that participants switched from semaglutide to placebo after 20 weeks regained significant weight (average 6.9%), while those who continued on semaglutide lost further weight (average 7.9%) over the next 48 weeks

Common mild side effects reported for both medications include indigestion, injection site reactions, fatigue, and dizziness

Positive experiences Users who report positive outcomes with oral tirzepatide drops typically describe a consistent pattern

GLP-1 long term use is generally well-supported by evidence

People with PCOS have higher levels of leptin, which may at first sound like they have better appetite regulation